Clinical Trials Browser

Has announcements × Carcinoma, Non-Small-Cell Lung × durvalumab × Clear all

NCT03800134 2025-06-11

AEGEAN

Phase 3 Active not recruiting

825 enrolled 1 FDA

Carcinoma, Carcinoma, Non-Small-Cell Lung

NCT02125461 2023-10-10

PACIFIC

Phase 3 Completed

713 enrolled 23 charts 1 FDA

Carcinoma, Non-Small-Cell Lung